CAXTON ASSOCIATES LP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$833,259
+204.4%
192,884
+364.3%
0.12%
+187.5%
Q2 2023$273,749
-73.7%
41,540
-72.9%
0.04%
-74.5%
Q1 2023$1,041,477
+8.7%
153,384
+18.3%
0.16%
+145.3%
Q4 2022$957,929
-16.0%
129,625
+12.4%
0.06%
-57.9%
Q3 2022$1,140,000
-6.9%
115,351
+2.7%
0.15%
+27.7%
Q2 2022$1,225,000
+162.3%
112,350
+172.0%
0.12%
+213.2%
Q1 2022$467,00041,3010.04%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders